William K. Hornung
2018
In 2018, William K. Hornung earned a total compensation of $371.5K as Chief Financial Officer at Diffusion Pharmaceuticals, a 186% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $49,429 |
---|---|
Option Awards | $106,200 |
Salary | $214,583 |
Other | $1,250 |
Total | $371,462 |
Hornung received $214.6K in salary, accounting for 58% of the total pay in 2018.
Hornung also received $49.4K in non-equity incentive plan, $106.2K in option awards and $1.3K in other compensation.
Rankings
In 2018, William K. Hornung's compensation ranked 12,738th out of 14,244 executives tracked by ExecPay. In other words, Hornung earned more than 10.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,738 out of 14,244 | 11th |
Division Manufacturing | 5,158 out of 5,765 | 11th |
Major group Chemicals And Allied Products | 1,951 out of 2,128 | 8th |
Industry group Drugs | 1,672 out of 1,817 | 8th |
Industry Pharmaceutical Preparations | 1,280 out of 1,391 | 8th |
Source: SEC filing on April 30, 2019.
Hornung's colleagues
We found three more compensation records of executives who worked with William K. Hornung at Diffusion Pharmaceuticals in 2018.